33
Participants
Start Date
March 21, 2023
Primary Completion Date
June 11, 2026
Study Completion Date
June 11, 2026
TAK-755
TAK-755 IV infusion
NOT_YET_RECRUITING
AKH - Medizinische Universitat Wien, Vienna
RECRUITING
Weill Cornell, New York
NOT_YET_RECRUITING
Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino, Torino
NOT_YET_RECRUITING
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan
RECRUITING
Duke University Medical Center, Durham
RECRUITING
Leo Jenkins Cancer Center/ECU School of Medicine, Greenville
NOT_YET_RECRUITING
Hospital General Universitario Gregorio Maranon, Madrid
RECRUITING
University of Florida - Shands, Gainesville
NOT_YET_RECRUITING
Hospital Universitario Virgen del Rocio, Seville
RECRUITING
Ohio State University, Columbus
NOT_YET_RECRUITING
Hospital Universitari i Politecnic La Fe, Valencia
NOT_YET_RECRUITING
Hospital de Cruces, Barakaldo
RECRUITING
Versiti Wisconsin, Inc., Milwaukee
RECRUITING
University of Minnesota Clinical Research Unit, Minneapolis
NOT_YET_RECRUITING
"General Hospital of Thessaloniki G. Papanikolaou", Thessaloniki
RECRUITING
University of Utah Health Sciences Center, Salt Lake City
RECRUITING
Massachusetts General Hospital, Boston
NOT_YET_RECRUITING
Brigham and Women's Hospital, Boston
RECRUITING
Beth Israel Deaconess Medical Center, Boston
RECRUITING
Rutgers University, New Brunswick
RECRUITING
University College London Hospital, London
RECRUITING
Royal Liverpool University Hospital, Liverpool
Lead Sponsor
Takeda Development Center Americas, Inc.
INDUSTRY
Takeda
INDUSTRY